Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
BMC Cancer|July 3, 2013
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activityFang Wu, Xiaoxia Ye, Peng Wang, et al.
Cancers|February 7, 2018
Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like FeaturesNidhi Gupta, Keshav Gopal, Chengsheng Wu, et al.
Scientific Reports|November 6, 2020
Reflection-mode virtual histology using photoacoustic remote sensing microscopyKevan Bell, Saad Abbasi, Deepak Dinakaran, et al.
Oncotarget|December 20, 2015
Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporterKeshav Gopal, Nidhi Gupta, Haifeng Zhang, et al.
Journal of Clinical Pathology|January 25, 2011
Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experienceMaria Copete, John Garratt, Blake Gilks, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Photon Absorption Remote Sensing Imaging of Breast Needle Core Biopsies Is Diagnostically Equivalent to Gold Standard H&E Histologic AssessmentJames E D Tweel, Benjamin R Ecclestone, Hager Gaouda, et al.
Cancer Treatment and Research Communications|June 6, 2021
Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancerAtul Batra, Nancy A Nixon, Gloria Roldan-Urgoiti, et al.
Breast Cancer Research : BCR|November 9, 2014
Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarraysKaren Jung, Peng Wang, Nidhi Gupta, et al.
Breast Cancer Research and Treatment|January 5, 2021
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug targetJohn R Mackey, Justine Lai, Utkarsh Chauhan, et al.
Oncotarget|April 22, 2017
High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancerNidhi Gupta, Karen Jung, Chengsheng Wu, et al.
Pageof 5